Genhong Cheng

InstitutionSuzhou Institute of Systems Medicine
AddressSuzhou
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 6 Covid-19 publications, with a maximum of 2 publications in August 2020
    All Publications
    Bar chart showing 164 publications over 20 distinct years, with a maximum of 13 publications in 2011
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Zhang S, Wang J, Cheng G. Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1. Proc Natl Acad Sci U S A. 2021 09 14; 118(37). PMID: 34452991.
      Citations: 2     Fields:    Translation:AnimalsCells
    2. Wu A, Wang L, Zhou HY, Ji CY, Xia SZ, Cao Y, Meng J, Ding X, Gold S, Jiang T, Cheng G. One year of SARS-CoV-2 evolution. Cell Host Microbe. 2021 04 14; 29(4):503-507. PMID: 33676588.
      Citations: 12     Fields:    Translation:Humans
    3. Li L, Li J, Gao M, Fan H, Wang Y, Xu X, Chen C, Liu J, Kim J, Aliyari R, Zhang J, Jin Y, Li X, Ma F, Shi M, Cheng G, Yang H. Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients. Front Immunol. 2020; 11:602395. PMID: 33488599.
      Citations: 16     Fields:    Translation:Humans
    4. Zu S, Deng YQ, Zhou C, Li J, Li L, Chen Q, Li XF, Zhao H, Gold S, He J, Li X, Zhang C, Yang H, Cheng G, Qin CF. 25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor. Cell Res. 2020 11; 30(11):1043-1045. PMID: 32811977.
      Citations: 24     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    5. Li C, Cheng G. Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin? Front Immunol. 2020; 11:1969. PMID: 32849658.
      Citations: 3     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    6. Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, Meng J, Zhu Z, Zhang Z, Wang J, Sheng J, Quan L, Xia Z, Tan W, Cheng G, Jiang T. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. Cell Host Microbe. 2020 03 11; 27(3):325-328. PMID: 32035028.
      Citations: 710     Fields:    Translation:CellsPHPublic Health
    7. Yang Z, Du J, Chen G, Zhao J, Yang X, Su L, Cheng G, Tang H. Coronavirus MHV-A59 infects the lung and causes severe pneumonia in C57BL/6 mice. Virol Sin. 2014 Dec; 29(6):393-402. PMID: 25547683.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    8. Wang G, Chen G, Zheng D, Cheng G, Tang H. PLP2 of mouse hepatitis virus A59 (MHV-A59) targets TBK1 to negatively regulate cellular type I interferon signaling pathway. PLoS One. 2011 Feb 18; 6(2):e17192. PMID: 21364999.
      Citations: 44     Fields:    Translation:AnimalsCells
    9. Zheng D, Chen G, Guo B, Cheng G, Tang H. PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production. Cell Res. 2008 Nov; 18(11):1105-13. PMID: 18957937.
      Citations: 81     Fields:    Translation:HumansAnimalsCells